trandolapril and Pain

trandolapril has been researched along with Pain* in 1 studies

Other Studies

1 other study(ies) available for trandolapril and Pain

Article	Year
The prevention of pain from sickle cell disease by trandolapril. Journal of the National Medical Association, 2007, Volume: 99, Issue:3 A 48-year-old African-American woman with both sickle cell anemia and chronic pain was treated with a hydrophobic angiotensin I-converting enzyme (ACE) inhibitor. This resulted in the complete resolution of her pain. When the ACE inhibitor was deliberately stopped, her pain recurred, only to cease again after the ACE inhibitor was deliberately resumed. The activation of ACE may be an early step in the arterial vaso-occlusion typical of sickle cell disease. Topics: Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Cell Hypoxia; Chronic Disease; Female; Gene Frequency; Genotype; Humans; Indoles; Middle Aged; Pain; Peptidyl-Dipeptidase A; Vasoconstriction	2007

Article

Year

The prevention of pain from sickle cell disease by trandolapril.

Journal of the National Medical Association, 2007, Volume: 99, Issue:3

A 48-year-old African-American woman with both sickle cell anemia and chronic pain was treated with a hydrophobic angiotensin I-converting enzyme (ACE) inhibitor. This resulted in the complete resolution of her pain. When the ACE inhibitor was deliberately stopped, her pain recurred, only to cease again after the ACE inhibitor was deliberately resumed. The activation of ACE may be an early step in the arterial vaso-occlusion typical of sickle cell disease.

Topics: Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Cell Hypoxia; Chronic Disease; Female; Gene Frequency; Genotype; Humans; Indoles; Middle Aged; Pain; Peptidyl-Dipeptidase A; Vasoconstriction

2007